ARVN

$7.09-5.72%visit website

ARVINAS, INC.

Market Cap

$464M

Live price × SEC shares (Oct 30, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.78

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

1.7

TTM to Sep 2026 · revenue

P/B

0.9

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	9,500	15,600	249,700	500	275,300
Research & development	61,100	60,300	52,600	46,900	220,900
Total operating expenses	84,100	79,400	85,600	59,600	308,700
Operating income	(74,600)	(63,800)	164,100	(59,100)	(33,400)
Interest expense			0.00	0.00
Pretax income		(57,500)	169,600	(53,700)
Income tax	200	100	200	200	700
Net income	(67,400)	(57,600)	169,400	(53,900)	(9,500)
EPS (basic) ($)		(0.90)	2.61	(0.82)	(0.07)
EPS (diluted) ($)		(0.90)	2.58	(0.82)	(0.08)
Weighted avg. shares (basic)		64,000	64,800	65,400
Weighted avg. shares (diluted)		64,000	65,700	65,400

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 35 more quarters, back to Mar 2017, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 8:09 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

37%

W/W -8.9pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-24	2026-06-24	Saik Andrew	Chief Financial Officer	Sale	5,696	$8.16	$46K	187.4K	View
2026-06-17	2026-06-18	Cacace Angela M	Chief Scientific Officer	Sale	2,576	$7.59	$20K	180.4K	View
2026-05-21	2026-05-22	Teel Randy	Director & President and CEO	Sale	2,209	$9.04	$20K	285.0K	View
2026-05-11	2026-05-13	Cacace Angela M	Chief Scientific Officer	Sale	9,657	$9.94	$96K	183.0K	View
2026-05-11	2026-05-13	Saik Andrew	Chief Financial Officer	Sale	11.1K	$9.94	$111K	193.1K	View